Market Overview

Detailed Research: Economic Perspectives on Microchip Technology, Net Element, First Majestic Silver, and Sanofi — What Drives Growth in Today's Competitive Landscape

Share:

NEW YORK, April 30, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Microchip Technology Incorporated (NASDAQ:MCHP), Net Element, Inc. (NASDAQ:NETE), First Majestic Silver Corp. (NYSE:AG), and Sanofi (NASDAQ:SNY), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

MCHP DOWNLOAD: http://Capital-Review.com/register/?so=MCHP
NETE DOWNLOAD: http://Capital-Review.com/register/?so=NETE
AG DOWNLOAD: http://Capital-Review.com/register/?so=AG
SNY DOWNLOAD: http://Capital-Review.com/register/?so=SNY

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Capital Review, available for free download at the links above, examine Microchip Technology Incorporated (NASDAQ:MCHP), Net Element, Inc. (NASDAQ:NETE), First Majestic Silver Corp. (NYSE:AG), and Sanofi (NASDAQ:SNY) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

MICROCHIP TECHNOLOGY INCORPORATED (MCHP) REPORT OVERVIEW

Microchip Technology's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Microchip Technology reported revenue of $1,374.70MM vs $994.20MM (up 38.27%) and analysts estimated basic earnings per share $0.21 vs -$1.07. For the twelve months ended March 31st, 2018 vs March 31st, 2017, Microchip Technology reported revenue of $3,980.80MM vs $3,407.80MM (up 16.81%) and analysts estimated basic earnings per share $1.10 vs $0.76 (up 44.74%). Analysts expect earnings to be released on May 8th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $1.33. The estimated EPS forecast for the next fiscal year is $6.15 and is expected to report on May 8th, 2019.

To read the full Microchip Technology Incorporated (MCHP) report, download it here: http://Capital-Review.com/register/?so=MCHP

-----------------------------------------

NET ELEMENT, INC. (NETE) REPORT OVERVIEW

Net Element's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Net Element reported revenue of $16.10MM vs $15.46MM (up 4.12%) and analysts estimated basic earnings per share -$0.40 vs -$1.70. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Net Element reported revenue of $65.79MM vs $60.06MM (up 9.53%) and analysts estimated basic earnings per share -$1.28 vs -$5.04. Analysts expect earnings to be released on May 13th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was -$0.42. The estimated EPS forecast for the next fiscal year is -$0.27 and is expected to report on April 6th, 2020.

To read the full Net Element, Inc. (NETE) report, download it here: http://Capital-Review.com/register/?so=NETE

-----------------------------------------

FIRST MAJESTIC SILVER CORP. (AG) REPORT OVERVIEW

First Majestic Silver's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, First Majestic Silver reported revenue of $74.13MM vs $61.17MM (up 21.19%) and analysts estimated basic earnings per share -$0.89 vs -$0.34. For the twelve months ended December 31st, 2018 vs December 31st, 2017, First Majestic Silver reported revenue of $300.93MM vs $252.29MM (up 19.28%) and analysts estimated basic earnings per share -$1.11 vs -$0.32. Analysts expect earnings to be released on May 8th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was -$0.06. The estimated EPS forecast for the next fiscal year is $0.16 and is expected to report on February 24th, 2020.

To read the full First Majestic Silver Corp. (AG) report, download it here: http://Capital-Review.com/register/?so=AG

-----------------------------------------

SANOFI (SNY) REPORT OVERVIEW

Sanofi's Recent Financial Performance

For the twelve months ended December 31st, 2018 vs December 31st, 2017, Sanofi reported revenue of $42,134.54MM vs $40,921.38MM (up 2.96%) and analysts estimated basic earnings per share $2.04 vs $3.79 (down 46.28%). Analysts expect earnings to be released on July 30th, 2019. The report will be for the fiscal period ending June 30th, 2019. The reported EPS for the same quarter last year was $0.74. The estimated EPS forecast for the next fiscal year is $3.56 and is expected to report on February 6th, 2020.

To read the full Sanofi (SNY) report, download it here: http://Capital-Review.com/register/?so=SNY

-----------------------------------------

ABOUT CAPITAL REVIEW

Capital Review is a nationally recognized publisher of financial analysis, research reports, and exclusive market reporting. Institutional investors, registered brokers, professional traders, and personal investment advisers rely on Capital Review to quantify public company valuations, discover opportunity across asset classes, stay informed about market-moving events, and read exclusive analysis of important material developments. With 14 offices worldwide, Capital Review staffs and manages certified and registered financial professionals, including Chartered Financial Analyst® (CFA®) designation holders and FINRA® BrokerCheck® certified individuals with current and valid CRD® number designations, to enable continuous coverage of topics relevant to its regular active reader base.

REGISTERED MEMBER STATUS

Capital Review's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Capital Review's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Capital Review have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Capital Review's Compliance department by Phone, at +1 (410) 280-7496, or by E-mail at compliance@Capital-Review.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Capital Review, Capital Review members, and/or Capital Review affiliates are not responsible for any gains or losses that result from the opinions expressed. Capital Review makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Capital Review has not been compensated for the publication of this press release by any of the above mentioned companies. Capital Review is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Morena Zambada, Media Department
Office: +1 (410) 280-7496
E-mail: media@Capital-Review.com

© 2019 Capital Review. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Capital-Review.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

View Comments and Join the Discussion!
 
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com